ABSTRACT
Capsular warning syndrome is characterized by recurrent transient ischemic attacks and is caused by microthrombosis or hypoperfusion of small-sized vessels. The pathophysiological basis of this syndrome is not well understood and currently a consensus has not been reached on its optimal treatment. In this study, we present 2 cases with favorable clinical outcomes after combined antithrombotic treatment with loading doses of clopidogrel and aspirin.
Subject(s)
Aspirin/administration & dosage , Internal Capsule/blood supply , Intracranial Thrombosis/drug therapy , Ischemic Attack, Transient/drug therapy , Ticlopidine/analogs & derivatives , Aged , Clopidogrel , Female , Humans , Internal Capsule/pathology , Internal Capsule/physiopathology , Intracranial Thrombosis/diagnosis , Intracranial Thrombosis/physiopathology , Ischemic Attack, Transient/diagnosis , Ischemic Attack, Transient/physiopathology , Male , Middle Aged , Ticlopidine/administration & dosageABSTRACT
OBJECTIVE: The aim of this study is to examine the direct medical costs and outcomes of patients with stroke. MATERIAL AND METHODS: The records of the patients admitted with ischemic and hemorrhagic stroke to the University of Trakya, School of Medicine, Department of Neurology were reviewed retrospectively in year 2007. Direct medical costs (total costs, radiological, laboratory, medicine, and other) were calculated, additionally cost per life saved and per life-year saved were calculated for stroke patients. RESULTS: The study group consisted of 328 patients (169 male/159 female) and mean age was 66.5 ± 12.4 years. Length of hospital stay was 10.7 ± 7.5 days. Mortality rate was 20.4% and the mRS score of the patients was 3.2 ± 2.1. The average cost of stroke was US$ 1677 ± 2964 (29.9% medicine, 19.9% laboratory, 12.8% neuroimaging, and 38% beds and staff). Cost per life saved and per life-year saved were US$ 2108 and US$ 1070, respectively. CONCLUSION: This is the first study in order to determine direct medical cost of stroke in Turkey, therefore, it may be guideline for disease-cost management of stroke.
Subject(s)
Brain Ischemia/economics , Cerebral Hemorrhage/economics , Stroke/economics , Acute Disease , Adult , Aged , Aged, 80 and over , Brain Ischemia/epidemiology , Cerebral Hemorrhage/epidemiology , Cost of Illness , Female , Fibrinolytic Agents/economics , Fibrinolytic Agents/therapeutic use , Hospital Costs , Humans , Infections/economics , Length of Stay , Magnetic Resonance Imaging/economics , Male , Middle Aged , Stroke/epidemiology , Thrombolytic Therapy/economics , Tomography, X-Ray Computed/economics , Turkey/epidemiologyABSTRACT
Methanol is a clear, colorless, and highly toxic liquid with a similar smell and taste to ethanol, and is found in many commercial products such as solvents and cleaning fluids. Severe methanol intoxication occurs after suicidal or accidental oral ingestion of solvents. A few patients with methanol intoxication via the transdermal route have been reported. We present a 47-year-old woman with acute transdermal methanol intoxication admitted to the emergency department with weakness, blurred vision, bilateral areactive mydriasis, and deterioration of consciousness.
